Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New research is raising an intriguing question in health care: could the same drugs millions of Americans take for weight loss and diabetes also help them survive longer after a serious diagnosis? A large study from Ontada, McKesson’s real-world data…
GLP-1 receptor agonists are truly transforming the medical landscape. Medications like Ozempic, Wegovy, and Mounjaro are offering millions of people a highly effective way to manage type 2 diabetes and achieve sustainable weight loss. For many patients, these treatments provide…
Millions of people now take a GLP-1 drug like Ozempic, Wegovy, or Mounjaro. These drugs have helped people lose weight. They’ve also helped people manage type 2 diabetes. Many people say these medications gave them back control of their health.…
People taking Ozempic and Wegovy keep reporting something strange. Their nail-biting habit, sometimes decades old, just stops. These drugs weren’t built for that. Semaglutide, the active ingredient in both, helps manage type 2 diabetes and supports weight loss. But patients…
If you recently started taking a weight-loss or diabetes medication like Ozempic, Wegovy, or Mounjaro, you might have noticed something a bit surprising. Your go-to snacks just do not taste the same anymore. A food you used to love might…
A 63-year-old woman in Massachusetts landed in the emergency room with abdominal pain that wouldn’t quit. The eventual fix wasn’t surgery. It wasn’t a new drug either. Instead, doctors turned to Diet Coke, about 1.5 liters a day. Her case…
New research suggests something surprising about GLP-1 drugs like Ozempic and Wegovy. Their effects might reach far beyond the scale. A working paper from the National Bureau of Economic Research found something notable. Women who lost weight on these medications…
A new study adds to the growing list of reasons doctors like GLP-1 medications. This time, the focus isn’t weight loss or blood sugar. It’s peripheral artery disease, a condition doctors find hard to treat and one that can lead…
GLP-1 receptor agonists are undeniably changing the way we approach metabolic health today. Millions of Americans are seeing incredible, life-changing results from medications like Ozempic, Wegovy, and Mounjaro. These treatments offer powerful support for managing type 2 diabetes and achieving…
A new study is raising eyebrows in both medical and public health circles. Specifically, researchers found that people currently taking GLP-1 receptor agonists appear significantly less likely to engage in violent behavior. This held even when those individuals drank heavily…